IMS001

· ImStem Biotechnology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IMS001, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis [Phase 1]

See pricing